KIN

Kindred Biosciences, Inc.
KIN

Overview Fund Activity
Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

73 hedge funds and large institutions have $226M invested in Kindred Biosciences, Inc. in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
+10
Holders Change %
+15.87%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
30
Reduced
18
Closed
6
Calls
–
Puts
$352K
Net Calls
-$352K
Net Calls Change
+$132K

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$10.4M
2
PWAM
2
Park West Asset Management
California
$63.9M
3
AI
3
Ariel Investments
Illinois
$23.6M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$10.1M
5
BlackRock
5
BlackRock
New York
$14.1M

Top Sellers

1
EC
1
EcoR1 Capital
California
$0
2
BRF
2
B. Riley Financial
California
$213K
3
RA
3
Royce & Associates
New York
$0
4
Wells Fargo
4
Wells Fargo
California
$3.43M
5
Citigroup
5
Citigroup
New York
$6K
Name Holding Trade Value Shares
Change 		Shares
Change %
RA
76
Royce & Associates
New York
– -$1.09M -126,000 Closed
D.E. Shaw & Co
77
D.E. Shaw & Co
New York
– -$114K -13,163 Closed
WS
78
Wedbush Securities
California
– -$87K -10,000 Closed
CMBA
79
C.M. Bidwell & Associates
Hawaii
– -$79K -9,145 Closed
PA
80
Parallel Advisors
California
– -$9K -1,075 Closed
1 2 3
4